Regulatory submission filed to initiate a Phase 2a trial of its drug candidate, PTI5803 in patients with focal cortical dysplasia (FCD), a rare and severe form of epilepsyPannTheraPi secures European ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
For parents, watching a child grow and develop is a source of immense joy and, sometimes, a few questions. While every child progresses at their own speed, understanding common developmental ...
Add Yahoo as a preferred source to see more of our stories on Google. Babies are curious about their world and want to explore. Jose Luis Pelaez Inc/DigitalVision via Getty Images Infant milestones ...
WASHINGTON — When President Joe Biden visited Angola last week, one of the highlights was his pledge of hundreds of millions of dollars for an ambitious trans-Africa rail project that would bring ...
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $200 million milestone payment from Sarepta Therapeutics (NASDAQ: SRPT). The ...
Tokyo, Japan and Cambridge, UK, 09 April 2026 - Nxera Pharma Co., Ltd. ('Nxera” or 'the Company”; TSE 4565) today announces ...
Dwyer Workforce Development celebrated a major milestone on Aug. 20, honoring its first three Dwyer Scholars to become licensed practical nurses, while 320 Dwyer Scholars earned their Certified ...
- Milestone earned upon reaching first enrollment target in a Phase 1/2 study of ARO-DM1 for the treatment of type 1 myotonic dystrophy PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results